PROMIS NEUROSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.94 USD | -3.00% |
|
+2.06% | +68.70% |
Chart calendar ProMIS Neurosciences, Inc.
ddf7cb79c7ccad0b1bbdeaa87ec828.fUp7aGXeAIjxVfVQHuZ-5vP5-sSYQtH1cdSeadP2oz0.EQcaAVeZNsWbCoUjeKFPkqusvfbtG6SiGrbBW7G8yEgQBRUkNptXuaYzwQ~677c4da73ae605725a8c64dd0fb90bb4
Upcoming events on ProMIS Neurosciences, Inc.
Past events on ProMIS Neurosciences, Inc.
| 2024-05-13 | Q1 2024 Earnings Release (Projected) |
| 2024-04-17 10:30 am | Bloom Burton & Co. Healthcare Investor Conference |
| 2024-04-12 | American Academy of Neurology Meeting |
| 2024-04-11 02:15 pm | Needham Healthcare Conference |
| 2024-04-09 02:00 pm | LD Micro Invitational Conference |
| 2024-04-01 04:15 pm | Q4 2023 Earnings Release |
| 2024-02-27 11:00 am | BIO CEO & Investor Conference |
| 2024-01-24 02:00 pm | Sequire Investor Summit |
| 2023-11-14 04:30 pm | Q3 2023 Earnings Release |
| 2023-09-12 04:30 pm | H.C. Wainwright Global Investment Conference |
| 2023-08-14 05:33 pm | Q2 2023 Earnings Release |
| 2023-07-15 | Alzheimer Association International Conference - PMN310 |
| 2023-06-29 09:30 am | Annual General Meeting |
| 2023-05-15 05:00 pm | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 | -31,5 -16,8 -87.76% | 0,00 0,00 - | -36,0 |
|
EBIT Million CAD | Released Forecast Spread | -7,40 -10,5 29.56% | 0,00 | -32,2 -17,1 -88.49% | -19,4 -18,6 -4.38% | -36,9 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -7,40 -10,5 29.56% | 0,00 | 0,00 0,00 - | -17,9 -17,4 -2.84% | -28,0 |
|
Net income Million CAD | Released Forecast Spread | -7,40 -10,5 29.56% | -11,8 | -24,9 -17,7 -40.68% | -17,9 -17,4 -2.84% | -38,0 |
|
EPS CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 0,00 - | -1,45 -1,46 0.23% | -1,51 |
| Announcement Date | 18/03/20 | 17/03/22 | 08/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | |||||
|
EBIT Million CAD | Released Forecast Spread | -3,90 | -3,45 -6,25 44.69% | -5,26 -4,28 -22.83% | ||||
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -3,24 -6,24 48.09% | -4,86 -4,21 -15.39% | |||||
|
Net income Million CAD | Released Forecast Spread | -3,11 | -3,24 -6,24 48.09% | -4,86 -4,21 -15.39% | -5,08 | -6,31 | -7,53 | -9,09 |
|
EPS CAD | Released Forecast Spread | -0,26 -0,46 42.95% | -0,12 -0,23 47.78% | -0,28 | -0,34 | -0,40 | -0,36 | |
| Announcement Date | 14/08/23 | 14/11/23 | 01/04/24 | - | - | - | - |
| 2024-05-15 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 09:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-07-23 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-25 01:00 am | ARGENX SE: Q2 2024 Earnings Release |
| 2024-07-29 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-30 | CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for ProMIS Neurosciences, Inc.
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PMN Stock
- Calendar ProMIS Neurosciences, Inc.